<p>SiBone（纳斯达克代码：SIBN - 获取免费报告）在周二发布给客户和投资者的研究报告中，Needham &amp; Company LLC 将其目标价格从 24.00 美元上调至 27.00 美元。该公司目前对该股票给予 “买入” 评级。Needham &amp; Company LLC 的目标价格意味着该公司股价有潜在的 46.66% 上涨空间。</p>
<ul>
<li>4 个近期盈利赢家在 5 月份迎来新动能</li>
</ul>
<p>其他一些研究公司也对 SIBN 发表了看法。摩根士丹利在 12 月 2 日的研究报告中将 SiBone 的目标价格从 20.00 美元上调至 23.00 美元，并给予该公司 “增持” 评级。Truist Financial 在 10 月 15 日的报告中将 SiBone 的目标价格从 22.00 美元下调至 20.00 美元，并为该公司设定了 “买入” 评级。最后，Weiss Ratings 在 12 月 8 日的报告中重申了对 SiBone 的 “卖出（e+）” 评级。四位股票研究分析师对该股票给予了买入评级，一位分析师则给予了卖出评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 23.75 美元。</p>
<p><strong>查看我们对 SiBone 的最新分析</strong></p>
<h2>SiBone 股票表现</h2>
<p>纳斯达克 SIBN 周二开盘价为 18.41 美元。该公司的速动比率为 6.62，流动比率为 7.97，债务与股本比率为 0.21。SiBone 的 52 周低点为 12.49 美元，52 周高点为 20.05 美元。该公司的 50 日移动平均线为 17.06 美元，200 日移动平均线为 16.82 美元。该股票的市值为 7.9883 亿美元，市盈率为 -36.10，贝塔值为 0.76。</p>
<p>SiBone（纳斯达克代码：SIBN - 获取免费报告）最近在 11 月 10 日发布了季度财报。该公司报告季度每股收益为（0.11）美元，超出分析师一致预期的（0.16）美元，超出幅度为 0.05 美元。SiBone 的股本回报率为 -12.86%，净利润率为 -11.24%。该公司在本季度的收入为 4866 万美元，而分析师预期为 4667 万美元。整体来看，分析师预测 SiBone 在当前财政年度的每股收益为 -0.78 美元。</p>
<h2>内部买卖情况</h2>
<p>在其他新闻中，内部人士 Anthony J. Recupero 于 11 月 17 日星期一出售了 3833 股公司的股票。该股票以平均价格 17.44 美元出售，总交易额为 66,847.52 美元。出售完成后，该内部人士直接持有 268,144 股公司股票，价值 4,676,431.36 美元。这代表其持股比例减少了 1.41%。该交易在向 SEC 提交的文件中披露，相关文件可在此链接查看。此外，SVP Michael A. Pisetsky 于 11 月 17 日星期一出售了 3328 股该股票。该股票以平均价格 17.41 美元出售，总价值为 57,940.48 美元。交易完成后，该高级副总裁直接持有 251,896 股公司股票，价值 4,385,509.36 美元。此交易代表其持股比例减少了 1.30%。该销售的 SEC 文件提供了更多信息。过去 90 天内，内部人士共出售了价值 2,698,252 美元的 147,128 股公司股票。公司内部人士持有公司股票的 4.00%。</p>
<h2>SiBone 的机构交易</h2>
<p>一些机构投资者最近调整了对该公司的持股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 SiBone 的持股增加了 4.5%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前拥有 24,426 股公司股票，价值 343,000 美元，此前在上个季度购买了额外的 1,053 股。Tudor Investment Corp ET AL 在第三季度将其在 SiBone 的持股增加了 0.8%。Tudor Investment Corp ET AL 目前拥有 258,032 股公司股票，价值 3,798,000 美元，此前在该期间购买了额外的 1,968 股。Rhumbline Advisers 在第一季度将其在 SiBone 的持股增加了 3.6%。Rhumbline Advisers 目前拥有 59,721 股公司股票，价值 838,000 美元，此前在上个季度购买了额外的 2,100 股。Franklin Resources Inc. 在第三季度将其在 SiBone 的持股增加了 8.3%。Franklin Resources Inc. 目前拥有 29,018 股公司股票，价值 427,000 美元，此前在上个季度购买了额外的 2,228 股。最后，EntryPoint Capital LLC 在第一季度将其在 SiBone 的持股增加了 21.5%。EntryPoint Capital LLC 目前拥有 14,787 股公司股票，价值 207,000 美元，此前在该期间购买了额外的 2,613 股。对冲基金和其他机构投资者持有公司股票的 98.11%。</p>
<h2>SiBone 公司简介</h2>
<p>（获取免费报告）</p>
<p>SI-BONE, Inc. 是一家医疗设备公司，致力于解决美国及国际上的骶骨盆解剖学的肌肉骨骼疾病。它提供专有的微创外科植入系统，以解决骶髂关节功能障碍和融合、成人畸形和退化以及骨盆创伤；以及可植入的骨产品。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 SiBone</li>
<li>投资的股票类型各不相同</li>
<li>不显眼的 Evergy Energy：您收入投资组合所需的 AI 提升</li>
<li>ESG 股票，投资者应了解的内容</li>
<li>辉瑞加大对减肥药的押注</li>
<li>成长股：它们是什么，示例及如何投资</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0lCTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0lCTg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>您现在应该投资 1,000 美元在 SiBone 吗？</h2>
<p>在您考虑 SiBone 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 SiBone 并不在名单上。</p>
<p>虽然 SiBone 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

SIBN

<p>Needham & Company LLC 将 SiBone 的目标股价从 24.00 美元上调至 27.00 美元，维持 “买入” 评级，表明潜在上涨幅度为 46.66%。其他公司则给出了不同的评级，平均目标为 23.75 美元。SiBone 的股票开盘价为 18.41 美元，近期有内部人士出售股票和机构交易活动。该公司报告的季度收益好于预期，但股本回报率为负，净利润率也不理想</p>

<p>SiBone (NASDAQ:SIBN - Get Free Report) had its price objective boosted by analysts at Needham &amp; Company LLC from $24.00 to $27.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a &#34;buy&#34; rating on the stock. Needham &amp; Company LLC's price target points to a potential upside of 46.66% from the company's previous close.</p>
<div class="lb-trans"><p>SiBone（纳斯达克代码：SIBN - 获取免费报告）在周二发布给客户和投资者的研究报告中，Needham &amp; Company LLC 将其目标价格从 24.00 美元上调至 27.00 美元。该公司目前对该股票给予 “买入” 评级。Needham &amp; Company LLC 的目标价格意味着该公司股价有潜在的 46.66% 上涨空间。</p>
</div><ul>
<li>4 Recent Earnings Winners Riding Fresh Momentum in May</li>
</ul>
<div class="lb-trans"><ul>
<li>4 个近期盈利赢家在 5 月份迎来新动能</li>
</ul>
</div><p>A number of other research firms have also weighed in on SIBN. Morgan Stanley boosted their price objective on shares of SiBone from $20.00 to $23.00 and gave the company an &#34;overweight&#34; rating in a research report on Tuesday, December 2nd. Truist Financial cut their price target on SiBone from $22.00 to $20.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, October 15th. Finally, Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of SiBone in a report on Monday, December 8th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $23.75.</p>
<div class="lb-trans"><p>其他一些研究公司也对 SIBN 发表了看法。摩根士丹利在 12 月 2 日的研究报告中将 SiBone 的目标价格从 20.00 美元上调至 23.00 美元，并给予该公司 “增持” 评级。Truist Financial 在 10 月 15 日的报告中将 SiBone 的目标价格从 22.00 美元下调至 20.00 美元，并为该公司设定了 “买入” 评级。最后，Weiss Ratings 在 12 月 8 日的报告中重申了对 SiBone 的 “卖出（e+）” 评级。四位股票研究分析师对该股票给予了买入评级，一位分析师则给予了卖出评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 23.75 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on SiBone</strong></p>
<div class="lb-trans"><p><strong>查看我们对 SiBone 的最新分析</strong></p>
</div><h2>SiBone Stock Performance</h2>
<div class="lb-trans"><h2>SiBone 股票表现</h2>
</div><p>NASDAQ SIBN opened at $18.41 on Tuesday. The company has a quick ratio of 6.62, a current ratio of 7.97 and a debt-to-equity ratio of 0.21. SiBone has a fifty-two week low of $12.49 and a fifty-two week high of $20.05. The business has a fifty day moving average of $17.06 and a 200-day moving average of $16.82. The stock has a market cap of $798.83 million, a price-to-earnings ratio of -36.10 and a beta of 0.76.</p>
<div class="lb-trans"><p>纳斯达克 SIBN 周二开盘价为 18.41 美元。该公司的速动比率为 6.62，流动比率为 7.97，债务与股本比率为 0.21。SiBone 的 52 周低点为 12.49 美元，52 周高点为 20.05 美元。该公司的 50 日移动平均线为 17.06 美元，200 日移动平均线为 16.82 美元。该股票的市值为 7.9883 亿美元，市盈率为 -36.10，贝塔值为 0.76。</p>
</div><p>SiBone (NASDAQ:SIBN - Get Free Report) last posted its quarterly earnings data on Monday, November 10th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.05. SiBone had a negative return on equity of 12.86% and a negative net margin of 11.24%.The firm had revenue of $48.66 million during the quarter, compared to analysts' expectations of $46.67 million. As a group, analysts predict that SiBone will post -0.78 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>SiBone（纳斯达克代码：SIBN - 获取免费报告）最近在 11 月 10 日发布了季度财报。该公司报告季度每股收益为（0.11）美元，超出分析师一致预期的（0.16）美元，超出幅度为 0.05 美元。SiBone 的股本回报率为 -12.86%，净利润率为 -11.24%。该公司在本季度的收入为 4866 万美元，而分析师预期为 4667 万美元。整体来看，分析师预测 SiBone 在当前财政年度的每股收益为 -0.78 美元。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖情况</h2>
</div><p>In other news, insider Anthony J. Recupero sold 3,833 shares of the company's stock in a transaction on Monday, November 17th. The stock was sold at an average price of $17.44, for a total transaction of $66,847.52. Following the completion of the sale, the insider directly owned 268,144 shares in the company, valued at $4,676,431.36. This represents a 1.41% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Michael A. Pisetsky sold 3,328 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $17.41, for a total value of $57,940.48. Following the completion of the transaction, the senior vice president directly owned 251,896 shares in the company, valued at $4,385,509.36. This trade represents a 1.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 147,128 shares of company stock worth $2,698,252 over the last 90 days. Company insiders own 4.00% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，内部人士 Anthony J. Recupero 于 11 月 17 日星期一出售了 3833 股公司的股票。该股票以平均价格 17.44 美元出售，总交易额为 66,847.52 美元。出售完成后，该内部人士直接持有 268,144 股公司股票，价值 4,676,431.36 美元。这代表其持股比例减少了 1.41%。该交易在向 SEC 提交的文件中披露，相关文件可在此链接查看。此外，SVP Michael A. Pisetsky 于 11 月 17 日星期一出售了 3328 股该股票。该股票以平均价格 17.41 美元出售，总价值为 57,940.48 美元。交易完成后，该高级副总裁直接持有 251,896 股公司股票，价值 4,385,509.36 美元。此交易代表其持股比例减少了 1.30%。该销售的 SEC 文件提供了更多信息。过去 90 天内，内部人士共出售了价值 2,698,252 美元的 147,128 股公司股票。公司内部人士持有公司股票的 4.00%。</p>
</div><h2>Institutional Trading of SiBone</h2>
<div class="lb-trans"><h2>SiBone 的机构交易</h2>
</div><p>A number of institutional investors have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in SiBone by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,426 shares of the company's stock worth $343,000 after purchasing an additional 1,053 shares in the last quarter. Tudor Investment Corp ET AL grew its stake in SiBone by 0.8% during the third quarter. Tudor Investment Corp ET AL now owns 258,032 shares of the company's stock worth $3,798,000 after buying an additional 1,968 shares during the period. Rhumbline Advisers increased its position in shares of SiBone by 3.6% in the first quarter. Rhumbline Advisers now owns 59,721 shares of the company's stock worth $838,000 after acquiring an additional 2,100 shares in the last quarter. Franklin Resources Inc. increased its position in shares of SiBone by 8.3% in the third quarter. Franklin Resources Inc. now owns 29,018 shares of the company's stock worth $427,000 after acquiring an additional 2,228 shares in the last quarter. Finally, EntryPoint Capital LLC raised its stake in shares of SiBone by 21.5% in the 1st quarter. EntryPoint Capital LLC now owns 14,787 shares of the company's stock valued at $207,000 after acquiring an additional 2,613 shares during the period. Hedge funds and other institutional investors own 98.11% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者最近调整了对该公司的持股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 SiBone 的持股增加了 4.5%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前拥有 24,426 股公司股票，价值 343,000 美元，此前在上个季度购买了额外的 1,053 股。Tudor Investment Corp ET AL 在第三季度将其在 SiBone 的持股增加了 0.8%。Tudor Investment Corp ET AL 目前拥有 258,032 股公司股票，价值 3,798,000 美元，此前在该期间购买了额外的 1,968 股。Rhumbline Advisers 在第一季度将其在 SiBone 的持股增加了 3.6%。Rhumbline Advisers 目前拥有 59,721 股公司股票，价值 838,000 美元，此前在上个季度购买了额外的 2,100 股。Franklin Resources Inc. 在第三季度将其在 SiBone 的持股增加了 8.3%。Franklin Resources Inc. 目前拥有 29,018 股公司股票，价值 427,000 美元，此前在上个季度购买了额外的 2,228 股。最后，EntryPoint Capital LLC 在第一季度将其在 SiBone 的持股增加了 21.5%。EntryPoint Capital LLC 目前拥有 14,787 股公司股票，价值 207,000 美元，此前在该期间购买了额外的 2,613 股。对冲基金和其他机构投资者持有公司股票的 98.11%。</p>
</div><h2>SiBone Company Profile</h2>
<div class="lb-trans"><h2>SiBone 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.</p>
<div class="lb-trans"><p>SI-BONE, Inc. 是一家医疗设备公司，致力于解决美国及国际上的骶骨盆解剖学的肌肉骨骼疾病。它提供专有的微创外科植入系统，以解决骶髂关节功能障碍和融合、成人畸形和退化以及骨盆创伤；以及可植入的骨产品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than SiBone</li>
<li>There Are Different Types of Stock To Invest In</li>
<li>Unassuming Evergy Energy: The AI Boost Your Income Portfolio Needs</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>Pfizer Adds to Its Big Bet on Weight Loss Drugs</li>
<li>Growth Stocks: What They Are, Examples and How to Invest</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 SiBone</li>
<li>投资的股票类型各不相同</li>
<li>不显眼的 Evergy Energy：您收入投资组合所需的 AI 提升</li>
<li>ESG 股票，投资者应了解的内容</li>
<li>辉瑞加大对减肥药的押注</li>
<li>成长股：它们是什么，示例及如何投资</li>
<li>ServiceNow 的 70 亿美元赌注：恐慌还是机会？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0lCTg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=SIBN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in SiBone Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在 SiBone 吗？</h2>
</div><p>Before you consider SiBone, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 SiBone 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SiBone wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 SiBone 并不在名单上。</p>
</div><p>While SiBone currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 SiBone 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

SI-BONE（纳斯达克代码：SIBN）的目标价格被上调至 27.00 美元